Obsessive-compulsive disorder during the COVID-19 pandemic

M. Van Ameringen; B. Patterson; J. Turna; G. Lethbridge; C. Goldman Bergmann; N. Lamberti; M. Rahat; B. Sideris; A. P. Francisco; N. Fineberg; S. Pallanti; G. Grassi; M. Vismara; U. Albert; R. Gedanke Shavitt; E. Hollander; J. Feusner; C. I. Rodriguez; P. Morgado; B. Dell'Osso

doi:10.1016/j.jpsychires.2022.02.001

Obsessive-compulsive disorder during the COVID-19 pandemic

M. Van Ameringen
, B. Patterson
, J. Turna
, G. Lethbridge
, C. Goldman Bergmann
, N. Lamberti
, M. Rahat
, B. Sideris
, A. P. Francisco
, N. Fineberg
, S. Pallanti
, G. Grassi
, M. Vismara
, U. Albert
, R. Gedanke Shavitt
, E. Hollander
, J. Feusner
, C. I. Rodriguez
, P. Morgado
, B. Dell'Osso

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	114-123
Number of pages	10
Journal	Journal of Psychiatric Research
Volume	149
DOIs	https://doi.org/10.1016/j.jpsychires.2022.02.001
State	Published - May 2022
Externally published	Yes

Access to Document

10.1016/j.jpsychires.2022.02.001

Cite this

Van Ameringen, M., Patterson, B., Turna, J., Lethbridge, G., Goldman Bergmann, C., Lamberti, N., Rahat, M., Sideris, B., Francisco, A. P., Fineberg, N., Pallanti, S., Grassi, G., Vismara, M., Albert, U., Gedanke Shavitt, R., Hollander, E., Feusner, J., Rodriguez, C. I., Morgado, P., & Dell'Osso, B. (2022). Obsessive-compulsive disorder during the COVID-19 pandemic. Journal of Psychiatric Research, 149, 114-123. https://doi.org/10.1016/j.jpsychires.2022.02.001

@article{631cc274abd04c6d880bcb15c74e390e,

title = "Obsessive-compulsive disorder during the COVID-19 pandemic",

author = "\{Van Ameringen\}, M. and B. Patterson and J. Turna and G. Lethbridge and \{Goldman Bergmann\}, C. and N. Lamberti and M. Rahat and B. Sideris and Francisco, \{A. P.\} and N. Fineberg and S. Pallanti and G. Grassi and M. Vismara and U. Albert and \{Gedanke Shavitt\}, R. and E. Hollander and J. Feusner and Rodriguez, \{C. I.\} and P. Morgado and B. Dell'Osso",

note = "Funding Information: Prof. Pallanti reports grant funding from NIH R21; consulting fees from Recordati, Angelini Pharma, GW Research Limited, Octapharma, SAGE Therapeutics INC, Biohaven Pharmaceuticals Inc and Gideon Ritcher PLC, all outside of the submitted work. Funding Information: Prof. Fineberg reports research funding from the National Institute for Health Research and COST Action; royalties from Oxford University Press; support for attending meetings/travel from the European college of Neuropsychopharmacology COST Action, International Forum of Mod and Anxiety disorders, British Association for Psychopharmacology, Royal College of Psychiatrists and the World Psychiatric Association; leadership roles at the International College of Obsessive Compulsive Spectrum Disorders (unpaid), MHRA and Orchard; she also leads an NHS treatment service for OCD, focusing on psychopharmacology and publishes on OCD treatments including psychopharmacology, all outside of the submitted work. Funding Information: Prof. Morgado reports receiving grants from FLAD, FCT and Funda{\c c}{\~a}o Calouste Gulbenkian; consulting fees from Janseen, Angelini, Lundbeck and Bial; honoraria from Astra Zeneca and Biogen as well as membership on the Board of Directors of Psychiatry of the Portuguese Medical Association, all outside of the submitted work. Funding Information: Dr. Gedanke Shavitt reports grant funding from the National Council for Scientific and Technological Development; honoraria from Lundbeck; and travel support from Lundbeck and Libbs all outside of the submitted work. Funding Information: Dr. Rodriguez has received research grant support from Biohaven Pharmaceuticals; has served as a consultant for Epiodyne and Biohaven Pharmaceuticals; and receives a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry, all outside of the submitted work. ",

year = "2022",

month = may,

doi = "10.1016/j.jpsychires.2022.02.001",

language = "English",

volume = "149",

pages = "114--123",

journal = "Journal of Psychiatric Research",

issn = "0022-3956",

publisher = "Elsevier Ltd.",

}

Van Ameringen, M, Patterson, B, Turna, J, Lethbridge, G, Goldman Bergmann, C, Lamberti, N, Rahat, M, Sideris, B, Francisco, AP, Fineberg, N, Pallanti, S, Grassi, G, Vismara, M, Albert, U, Gedanke Shavitt, R, Hollander, E, Feusner, J, Rodriguez, CI, Morgado, P & Dell'Osso, B 2022, 'Obsessive-compulsive disorder during the COVID-19 pandemic', Journal of Psychiatric Research, vol. 149, pp. 114-123. https://doi.org/10.1016/j.jpsychires.2022.02.001

TY - JOUR

T1 - Obsessive-compulsive disorder during the COVID-19 pandemic

AU - Van Ameringen, M.

AU - Patterson, B.

AU - Turna, J.

AU - Lethbridge, G.

AU - Goldman Bergmann, C.

AU - Lamberti, N.

AU - Rahat, M.

AU - Sideris, B.

AU - Francisco, A. P.

AU - Fineberg, N.

AU - Pallanti, S.

AU - Grassi, G.

AU - Vismara, M.

AU - Albert, U.

AU - Gedanke Shavitt, R.

AU - Hollander, E.

AU - Feusner, J.

AU - Rodriguez, C. I.

AU - Morgado, P.

AU - Dell'Osso, B.

N1 - Funding Information: Prof. Pallanti reports grant funding from NIH R21; consulting fees from Recordati, Angelini Pharma, GW Research Limited, Octapharma, SAGE Therapeutics INC, Biohaven Pharmaceuticals Inc and Gideon Ritcher PLC, all outside of the submitted work. Funding Information: Prof. Fineberg reports research funding from the National Institute for Health Research and COST Action; royalties from Oxford University Press; support for attending meetings/travel from the European college of Neuropsychopharmacology COST Action, International Forum of Mod and Anxiety disorders, British Association for Psychopharmacology, Royal College of Psychiatrists and the World Psychiatric Association; leadership roles at the International College of Obsessive Compulsive Spectrum Disorders (unpaid), MHRA and Orchard; she also leads an NHS treatment service for OCD, focusing on psychopharmacology and publishes on OCD treatments including psychopharmacology, all outside of the submitted work. Funding Information: Prof. Morgado reports receiving grants from FLAD, FCT and Fundação Calouste Gulbenkian; consulting fees from Janseen, Angelini, Lundbeck and Bial; honoraria from Astra Zeneca and Biogen as well as membership on the Board of Directors of Psychiatry of the Portuguese Medical Association, all outside of the submitted work. Funding Information: Dr. Gedanke Shavitt reports grant funding from the National Council for Scientific and Technological Development; honoraria from Lundbeck; and travel support from Lundbeck and Libbs all outside of the submitted work. Funding Information: Dr. Rodriguez has received research grant support from Biohaven Pharmaceuticals; has served as a consultant for Epiodyne and Biohaven Pharmaceuticals; and receives a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry, all outside of the submitted work.

PY - 2022/5

Y1 - 2022/5

UR - https://www.scopus.com/pages/publications/85125724336

U2 - 10.1016/j.jpsychires.2022.02.001

DO - 10.1016/j.jpsychires.2022.02.001

M3 - Article

C2 - 35272208

AN - SCOPUS:85125724336

SN - 0022-3956

VL - 149

SP - 114

EP - 123

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

ER -